SYRES is CIR and CII accredited: what this means for you

SYRES is CIR and CII accredited: what this means for you

Good news for our current and future partners: SYRES is officially approved for the Research Tax Credit (CIR) and the Innovation Tax Credit (CII) until 2027.

But in practical terms, what does this mean for you?

When you collaborate with Syres on studies involving a research or innovation dimension (development of new protocols, exploration of mechanisms of action, advanced consumer testing, etc.), part of the expenses incurred may be eligible for a tax credit.

It's a powerful tool for: Supporting your innovation efforts, Reducing your R&D investments, Optimizing your product development budgets. A 30% tax credit on eligible research expenses, up to €100 million per year, 5% beyond that, And for projects falling under the Innovation Tax Credit (CII), additional support for the development of innovative products.

Consumer studies aimed at validating the effectiveness or acceptability of a new formula, Development of novel protocols to measure well-being or emotions, Advanced processing and analysis of data from panels, Integration of new technologies (AI, analytical tools, etc.) into survey processes.

Because we combine: Recognized expertise in sensory testing, qualitative and quantitative studies, A capacity for constant innovation, particularly in digital tools and tailor-made protocols, A collaborative approach with your R&D, marketing or regulatory teams.

Do you have a development, consumer study or claim validation project?

We help you maximize their value… and optimize your budgets. Contact our team to discuss the opportunities offered by the Research Tax Credit (CIR) and Innovation Tax Credit (CII) for your future projects!

Let's prove the effectiveness of your products